Evaluation of new guidelines for ROP screening in Sweden using SWEDROP - a national quality register

Research output: Contribution to journalArticle

Standard

Evaluation of new guidelines for ROP screening in Sweden using SWEDROP - a national quality register. / Holmstrom, Gerd; Hellstrom, Ann; Jakobsson, Peter; Lundgren, Pia; Tornqvist, Kristina; Wallin, Agneta.

In: Acta Ophthalmologica, Vol. 93, No. 3, 2015, p. 265-268.

Research output: Contribution to journalArticle

Harvard

APA

CBE

MLA

Vancouver

Author

Holmstrom, Gerd ; Hellstrom, Ann ; Jakobsson, Peter ; Lundgren, Pia ; Tornqvist, Kristina ; Wallin, Agneta. / Evaluation of new guidelines for ROP screening in Sweden using SWEDROP - a national quality register. In: Acta Ophthalmologica. 2015 ; Vol. 93, No. 3. pp. 265-268.

RIS

TY - JOUR

T1 - Evaluation of new guidelines for ROP screening in Sweden using SWEDROP - a national quality register

AU - Holmstrom, Gerd

AU - Hellstrom, Ann

AU - Jakobsson, Peter

AU - Lundgren, Pia

AU - Tornqvist, Kristina

AU - Wallin, Agneta

PY - 2015

Y1 - 2015

N2 - PurposeTo investigate whether recent Swedish guidelines for Retinopathy of Prematurity (ROP) screening, that is, a gestational age (GA) at birth of <31weeks (w), are applicable in a new national cohort of prematurely born infants. MethodsSWEDROP is a national register for ROP, initiated in 2006. The present paper reports on data from the register on various aspects of screening for ROP in infants born between 2010 and 2011 and compares the results with those for a previously published cohort born between 2008 and 2009. ResultsDuring the study period, 1744 infants were screened for ROP. Mean GA was 28.4w (22-31), and mean birth weight was 1239g (382-2615). Screening started at postnatal age (PNA) 5.4w (0.4-13.3) and postmenstrual age (PMA) 33.8 w (24.9-50.1) Mean number of examinations was 5.4 per infant (1-38). Mild (stages 1-2) and severe ( stage 3) ROP was found in 15.4% and 8.7%, respectively. Treatment was performed in 4.2% (73/1744) of the infants, but in none with a GA of 30weeks or more. The first treatment was performed at a mean PNA and PMA of 12.7 w (7.7-25.4) and 37.4 w (32.1-51.4), respectively. ConclusionsRecently introduced new guidelines for ROP screening in Sweden remain applicable. Reassuringly, in infants born between 2010 and 2011, incidence of ROP, frequency and timing of treatment, frequency and timing of examinations and national coverage of ROP screening remained almost identical to those for a previous cohort from 2008 to 2009. The two SWEDROP cohorts provide a basis for discussion among Swedish ophthalmologists and neonatologists on the question of further lowering the upper screening limit with 1week.

AB - PurposeTo investigate whether recent Swedish guidelines for Retinopathy of Prematurity (ROP) screening, that is, a gestational age (GA) at birth of <31weeks (w), are applicable in a new national cohort of prematurely born infants. MethodsSWEDROP is a national register for ROP, initiated in 2006. The present paper reports on data from the register on various aspects of screening for ROP in infants born between 2010 and 2011 and compares the results with those for a previously published cohort born between 2008 and 2009. ResultsDuring the study period, 1744 infants were screened for ROP. Mean GA was 28.4w (22-31), and mean birth weight was 1239g (382-2615). Screening started at postnatal age (PNA) 5.4w (0.4-13.3) and postmenstrual age (PMA) 33.8 w (24.9-50.1) Mean number of examinations was 5.4 per infant (1-38). Mild (stages 1-2) and severe ( stage 3) ROP was found in 15.4% and 8.7%, respectively. Treatment was performed in 4.2% (73/1744) of the infants, but in none with a GA of 30weeks or more. The first treatment was performed at a mean PNA and PMA of 12.7 w (7.7-25.4) and 37.4 w (32.1-51.4), respectively. ConclusionsRecently introduced new guidelines for ROP screening in Sweden remain applicable. Reassuringly, in infants born between 2010 and 2011, incidence of ROP, frequency and timing of treatment, frequency and timing of examinations and national coverage of ROP screening remained almost identical to those for a previous cohort from 2008 to 2009. The two SWEDROP cohorts provide a basis for discussion among Swedish ophthalmologists and neonatologists on the question of further lowering the upper screening limit with 1week.

KW - guidelines

KW - national register

KW - retinopathy of prematurity

KW - screening

U2 - 10.1111/aos.12506

DO - 10.1111/aos.12506

M3 - Article

VL - 93

SP - 265

EP - 268

JO - Acta Ophthalmologica

JF - Acta Ophthalmologica

SN - 1755-3768

IS - 3

ER -